NILOTINIB STADA

Capsule, hard, 150mg
RxActive license

Active substance (INN)

nilotinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength150mg
PackagingUkupno 112 kapsula tvrdih u blisteru (16x7) u kartonskoj kutiji
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01EA03)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateFebruary 20, 2025

Analogs in Montenegro

6

Other medicines with the same active substance

NILMATRx
Capsule, hard, 150mgGalenika a.d. Beograd
NILMATRx
Capsule, hard, 200mgGalenika a.d. Beograd
NILOTINIB STADARx
Capsule, hard, 50mgStada Arzneimittel AG
NILOTINIB STADARx
Capsule, hard, 200mgStada Arzneimittel AG
TASIGNARx
Capsule, hard, 150mgNovartis Pharmaceutical Manufacturing LLC
TASIGNARestricted
Capsule, hard, 200mgNovartis Pharma Stein AG
Source: CInMED register